SCHEMBL16003779

SCHEMBL16003779

CCCc1n[nH]c2c(=O)[nH]c(-c3cc(NC4CCN(c5ncc(C(=O)NO)cn5)CC4)ccc3OCC)nc12

nearest known ligand 0.78

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 20/20 0.78
HDAC1 Q13547 20/20 0.78
HDAC6 Q9UBN7 20/20 0.78
HDAC2 Q92769 15/20 0.78
HDAC3 O15379 6/20 0.78
NCOR2 Q9Y618 6/20 0.78
PDE9A O76083 1/20 0.55
PDE6C P51160 1/20 0.55
PDE3A Q14432 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16003768 0.91 PDE5A (0.78) PDE5AHDAC1HDAC6HDAC2HDAC3
SCHEMBL16003782 0.88 PDE5A (0.71) PDE5AHDAC1HDAC6HDAC2HDAC3
SCHEMBL17390237 0.87 PDE5A (1.00) PDE5AHDAC1HDAC6HDAC2HDAC3
SCHEMBL16003751 0.87 PDE5A (0.78) PDE5AHDAC1HDAC6HDAC2HDAC3
SCHEMBL16003673 0.84 PDE5A (0.78) PDE5AHDAC1HDAC6HDAC2HDAC3
SCHEMBL17390230 0.81 PDE5A (0.88) PDE5AHDAC1HDAC6HDAC2HDAC3
SCHEMBL16003681 0.80 PDE5A (0.72) PDE5AHDAC1HDAC6HDAC2HDAC3
SCHEMBL17390207 0.80 PDE5A (0.85) PDE5AHDAC1HDAC6HDAC2HDAC3
SCHEMBL16003668 0.79 PDE5A (0.71) PDE5AHDAC1HDAC6HDAC2HDAC3
SCHEMBL16003677 0.79 PDE5A (1.00) PDE5AHDAC1HDAC6HDAC2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016120432-A1 COMPOUNDS AND METHODS FOR ANTICOAGULATION THERAPY FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA (ES) 2016-08-04 WO disclosed
WO-2014131855-A1 NOVEL COMPOUNDS AS DUAL INHIBITORS OF PHOSPHODIESTERASES AND HISTONE DEACETYLASES FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA (ES) 2014-09-04 WO disclosed